Figures and data in Cryo-EM structures of human ZnT8 in both outward- and inward-facing conformations

Figures
Videos
Tables
Additional files

5 figures, 1 video, 1 table and 2 additional files

Figures

Figure 1 with 6 supplements

Download asset Open asset

Overall structure of HsZnT8-DM in the outward-facing conformation.

(a) Cryo-EM reconstruction of HsZnT8-DM in the outward-facing conformation (contour level: 0.018, 4.8 σ). The two subunits are colored in blue and green, respectively. (b) The ribbon representation of the HsZnT8-DM dimer in the side view. (c) The cylinder representation of the HsZnT8-DM dimer in the top view with TMs from one subunit labeled. (d) The ribbon representation of a single HsZnT8-DM subunit with secondary structural elements labeled. (e) Zoomed-in views of the interface between the two adjacent CTDs in two orthogonal orientations. (f) Zoomed-in view of the interface between the two adjacent TMDs.

Figure 1—figure supplement 1

Download asset Open asset

Sequence alignment of HsZnT8 (Q8IWU4), EcYiiP (P69380) and SoYiiP (Q8E919).

The protein accession codes for HsZnT8 and its bacterial orthologs are indicated.

Figure 1—figure supplement 2

Download asset Open asset

Purification of the HsZnT8.

(a) Topology and domain organization of the HsZnT8 subunit. The starting points of isoform A and B are labeled. (b) A representative size-exclusion chromatography of HsZnT8-DM (left) and the SDS–PAGE of the peak fractions (right, coomassie staining). Arrow indicates the peak fraction collected for structural determination.

Figure 1—figure supplement 3

Download asset Open asset

Cryo-EM analysis of the HsZnT8-DM in the absence of Zn²⁺.

(a) Representative electron micrograph and 2D class averages of the HsZnT8-DM. (Scale bar: 200 Å) (b) Cryo-EM map colored by local resolution. (c) Euler angle distribution of particles used in the final 3D reconstructions. (d) The gold-standard Fourier shell correlation curve for the cryo-EM map shown in Figure 1a. (e) FSC curve for the refined model versus the cryo-EM map. (f) Flowchart of cryo-EM data processing.

Figure 1—figure supplement 4

Download asset Open asset

Cryo-EM density of HsZnT8-DM in the absence of Zn²⁺.

(a) Representative density maps of CTD domain and each TM of HsZnT8-DM. (b) The cryo-EM map of HsZnT8-DM low-pass filtered to 5 Å showing the clear density (indicated by a dash box) for the linker between HCH motif and the N-terminus of TM1.

Figure 1—figure supplement 5

Download asset Open asset

Structural comparison between HsZnT8 and EcYiiP in outward-facing conformation.

(a) Overall structures of HsZnT8 (blue) and EcYiiP (pink, PDB: 3H90) in outward-facing conformation. (b) Superposition of the dimeric HsZnT8 (blue) and EcYiiP (pink). (c) Superposition of the TMDs of HsZnT8 (blue) and EcYiiP (pink). (d) Superposition of the CTDs of HsZnT8 (blue) and EcYiiP (pink), showing the different locations of the Zn²⁺ binding sites in CTD. (e) Superposition of the TM2-3 loops of HsZnT8 (blue) and EcYiiP (pink), showing the different locations of the Zn²⁺ binding sites at the CTD/TMD interface. (f) RMSD value of TMD and CTD between HsZnT8 and EcYiiP in outward-facing conformation. RMSD was calculated based on only the position of C-α atom.

Figure 1—figure supplement 6

Download asset Open asset

Sequence alignment of ZnT8 from human (Q8IWU4), mouse (Q8BGG0), western clawed frog (Q5XHB4), chicken (A0A1D5NY81) and zebrafish (A0A0R4IFM6).

The starting residues of isoform A and B are labeled. The Zn²⁺ binding sites residues are marked with boxes. The protein accession codes for different ZnT8 orthologs are indicated.

Figure 2 with 1 supplement

Download asset Open asset

The Zn²⁺ binding sites in HsZnT8.

(a) Overall view of Zn²⁺ binding sites in HsZnT8-WT. The location of each site is indicated by a dash box. (b) and (c) Detailed views of S_CD1 and S_CD2 in the structure of HsZnT8-DM in the absence of Zn²⁺. The cryo-EM densities are displayed as blue mesh (6 σ). (d) , (e) and (f) Detailed views of S_IF and S_TM in the structures of HsZnT8-DM in the absence of Zn²⁺ and HsZnT8-WT in the presence of Zn²⁺. The cryo-EM densities are displayed as blue mesh (6 σ). The density differences between the cryo-EM maps of HsZnT8-DM in the absence of Zn²⁺ and HsZnT8-WT in the presence of Zn²⁺ are shown as orange blobs (8 σ). (g) Representative fluorescence traces of vesicular Zn²⁺ uptake for the cells expressing wild-type HsZnT8 or its mutants. Non-induced HEK293F cells (empty) was used as the negative control. Expression levels of HsZnT8 wild type and mutants were monitored by western blot using anti-flag antibody. Mouse anti-β-actin was used as a loading control. (h) Relative Zn²⁺ uptake rate between HsZnT8 and its mutants (Mean ± SD). The uptake rates were normalized to the expression levels of HsZnT8. Each experiment was repeated four times. Significance calculated using two-tailed students t-test; between wild-type and mutants; ***p<0.001.

Figure 2—source data 1 Source data for Figure 2g.: https://cdn.elifesciences.org/articles/58823/elife-58823-fig2-data1-v2.xlsx
Download elife-58823-fig2-data1-v2.xlsx
Figure 2—source data 2 Source data for Figure 2h.: https://cdn.elifesciences.org/articles/58823/elife-58823-fig2-data2-v2.xlsx
Download elife-58823-fig2-data2-v2.xlsx

Figure 2—figure supplement 1

Download asset Open asset

Cryo-EM analysis of the HsZnT8-WT in the presence of Zn²⁺.

(a) 3D reconstruction of HsZnT8-WT in the presence of Zn²⁺ (left) and the corresponding ribbon representation of this complex (right). The 4 Zn²⁺ binding sites in one subunit are labeled. The bound Zn²⁺ ions are shown as pink spheres. (b) The gold-standard Fourier shell correlation curve for the cryo-EM map shown in (a). (c) FSC curve for the refined model versus the cryo-EM map. (d) Representative density maps of CTD domain and each TM of HsZnt8-WT in the presence of Zn²⁺. (e) Superposition between the models of HsZnT8-DM in the absence of Zn²⁺ (blue) and HsZnT8-WT in the presence of Zn²⁺ (pink). Inset: zoomed-in view of the superposition at S_TM site.

Figure 3 with 3 supplements

Download asset Open asset

Structural transitions between outward- and inward-facing conformations.

(a) 3D reconstruction of HsZnT8-WT in the absence of Zn²⁺ and the ribbon representation of the model fitted into cryo-EM map. (b) Top view of the TMD (TMs 1–6) from the inward-facing subunit in ribbon representation fitted into cryo-EM map. (c) The surface-rendered models of an outward-facing subunit from the HsZnT8-DM structure (left) and an inward-facing subunit from the HsZnT8-WT structure obtained in the absence of Zn²⁺ (right). The brown dashed lines indicate the opening of S_TM to either the luminal or the cytosolic side. (d) Superposition between the structures of HsZnT8-DM dimer (grey) and HsZnT8-WT dimer (orange) both obtained in the absence of Zn²⁺ (e) Superposition of the TMD structures between the outward-facing subunit from HsZnT8-DM (with TMs colored in grey) and the inward-facing subunit from HsZnT8-WT (with TMs 1–2 colored in brown, TMs 4–5 in green and TMs 3 and six in blue), revealing two different types of rocking motions (indicated by the arrows).

Figure 3—figure supplement 1

Download asset Open asset

Cryo-EM analysis of the HsZnT8-WT in the absence of Zn²⁺.

(a) Representative electron micrograph and 2D class averages of the HsZnT8-WT in the absence of Zn²⁺. (Scale bar: 200 Å) (b) Cryo-EM map colored by local resolution. (c) Euler angle distribution of particles used in the final 3D reconstructions. (d) The gold-standard Fourier shell correlation curve for the cryo-EM map shown in Figure 3a. (e) FSC curve for the refined model versus the cryo-EM map. (f) Flowchart of cryo-EM data processing. (g) Representative density maps of each TM of HsZnT8-WT in the absence of Zn²⁺.

Figure 3—figure supplement 2

Download asset Open asset

Structural comparison between HsZnT8 in outward- and inward-facing conformations.

(a) Structures of HsZnT8 TMD in outward- (blue) and inward-facing (green) conformation. The loops connecting TMs are omitted for clarity. (b) Superposition of the HsZnT8 TMD in outward- (blue) and inward-facing (green) conformations. (c) The angular change of each TM between outward- and inward-facing confirmations. (d) Solvent accessible cavities (grey) in outward- and inward-facing conformations.

Figure 3—figure supplement 3

Download asset Open asset

Structural comparison between HsZnT8 and SoYiiP in inward-facing conformation.

(a) Overall structures of HsZnT8 (blue) in heterogeneous conformation. (b) Overall structure of SoYiiP (yellow, PDB: 5VRF) in inward-facing conformation. (c) Superposition of the dimeric HsZnT8 (blue) and SoYiiP (yellow). (d) Superposition of the TMDs of HsZnT8 (blue) and SoYiiP (yellow). (e) RMSD value of TMD and CTD between HsZnT8 and SoYiiP in inward-facing conformation. RMSD was calculated based on only the position of C-α atom.

Figure 4 with 1 supplement

Download asset Open asset

Proposed working model of HsZnT8.

(a) A cartoon representation illustrates that each ZnT8 subunit may shuttle between inward- and outward-facing conformations independently during the Zn²⁺ transport cycle. (b) Schematic representation of a simplified model for the transport cycle of ZnT8. For simplicity, both subunits in a ZnT8 dimer are drawn in homogeneous conformations, but they likely carry out Zn²⁺/H⁺ exchange function independent from each other, as shown in a.

Figure 4—figure supplement 1

Download asset Open asset

Mapping of the disease-associated point mutations onto HsZnT8.

Several of these mutations are found in other ZnTs, but conserved in ZnT8.

Author response image 1

Download asset Open asset

Videos

Video 1

Download asset

posterframe for video — Structural transitions of the TMD of HsZnT8 between outward- and inward-facing conformations.

Tables

Key resources table

Reagent type (species) or resource	Designation	Source or reference	Identifiers	Additional information
Strain, strain background (Escherichia coli)	TOP10	Thermo Fisher Scientific	Cat# 18258012
Strain, strain background (Escherichia coli)	DH10bac	Thermo Fisher Scientific	Cat# 10361012
Cell line (Spodoptera frugiperda)	Sf9 cells	Thermo Fisher Scientific	Cat# 11496015; RRID:CVCL_0549
Cell line (Homo sapiens)	FreeStyle 293 F cells	Thermo Fisher Scientific	Cat# R79007; RRID:CVCL_D603
Recombinant DNA reagent	pEZT-BM	DOI:10.1016/j.str.2016.03.004	Addgene:74099
Transfected construct (Homo-sapiens)	pEZT-BM-ZNT8-N_Flagand mutations	This paper	N/A	transfected construct (human)
Antibody	Mouse monoclonal anti-FLAG tag	Sigma	Cat# F1804	WB (1:5000)
Antibody	Mouse monoclonal anti-b-actin	Santa Cruz Biotechnology	Cat# sc-69879; RRID:AB_1119529	WB (1:200)
Antibody	Mouse IgG HRP linked whole Ab	GE healthcare	Cat# NA931V; RRID:AB_772210	WB (1:10000)
Chemical compound, drug	Sodium Butyrate	Sigma-Aldrich	Cat# 303410
Chemical compound, drug	n-Dodecyl-b-Maltopyranoside	Anatrace	Cat# D310, D310s
Chemical compound, drug	Cholesteryl hemisuccinate	Sigma-Aldrich	Cat# C6512
Chemical compound, drug	Lauryl Maltose Neopentyl Glycol	Anatrace	Cat# NG310
Chemical compound, drug	Digitonin	Sigma	Cat# D141
Chemical compound, drug	1,10-Phenanthroline	Sigma	Cat# 131377
Chemical compound, drug	FluoZin−3	Thermo Fisher Scientific	Cat# F24194
Peptide, recombinant protein	3X FLAG Peptide	Sigma	Cat# F4799
Software, algorithm	MotionCor2	Zheng et al., 2017	https://emcore.ucsf.edu/ucsf-software
Software, algorithm	GCTF	Zhang, 2016	https://www2.mrc-lmb.cam.ac.uk/research/locally-developed-software/zhang-software/#gctf
Software, algorithm	RELION	Scheres, 2012	http://www2.mrc-lmb.cam.ac.uk/relion
Software, algorithm	Chimera	Pettersen et al., 2004	https://www.cgl.ucsf.edu/chimera; RRID:SCR_004097
Software, algorithm	PyMol	Schrödinger	https://pymol.org/2; RRID:SCR_000305
Software, algorithm	COOT	Emsley et al., 2010	https://www2.mrc-lmb.cam.ac.uk/ personal/pemsley/coot; RRID:SCR_014222
Software, algorithm	PHENIX	Adams et al., 2010	https://www.phenix-online.org
Software, algorithm	GraphPad Prism	GraphPad Software	https://www.graphpad.com/scientific-software/prism
Software, algorithm	OriginPro 8	OriginLab Corp.	https://www.originlab.com
Other	Superose 6 Increase10/300 GL	GE Healthcare	Cat# 29091596
Other	Anti-DYKDDDDK G1 Affinity Resin	GeneScript	Cat# 10362101
Other	Amicon Ultra-15 Centrifugal Filter Units	Milliporesigma	Cat# UFC9100
Other	Quantifoil R 1.2/1.3 grid Au300	quantifoil	Cat# Q37572
Other	Cellfectin	Invitrogen	Cat# 10362100